ZHANNA SHELEG: Open Payments
NPI 1912653577 · CHANDLER, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$464 in 24 payments from 9 companies in 2025. Trend: 2023 $545 · 2024 $523 · 2025 $464
Food & beverage: $464
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $141 |
| INTUITIVE SURGICAL, INC. | 1 | $129 |
| Eisai Inc. | 2 | $67 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
Products named: Da Vinci Surgical System, QULIPTA, Leqembi, UBRELVY, VRAYLAR, GEMTESA, ZENPEP, TRELEGY ELLIPTA.
Industry payments across AZ — which companies pay providers there.
